Navigation Links
Targeting the more lethal form of the cancer rhabdomyosarcoma
Date:5/25/2009

Rhabdomyosarcoma (RMS) is an aggressive muscle cancer that mostly affects children. The most common forms of RMS are embryonal rhabdomyosarcoma (ERMS) and alveolar rhabdomyosarcoma (ARMS). Although ARMS is less common than ERMS, it is associated with a much higher rate of mortality. A therapy tailored to the ARMS form of RMS is therefore badly needed. A team of researchers, at the Hospital for Sick Children, Toronto, and Monash Institute of Medical Research, Australia, has now provided hope that it might be possible to develop such a therapy by showing that the protein ILK promotes the growth of ARMS cells, whereas it suppresses the growth of ERMS cells.

The team, led by David Malkin and Gregory Hannigan, determined that the signaling protein JNK mediated these differing effects of ILK. Knocking down expression of ILK in ERMS cells induced activation of JNK and promoted tumor cell growth both in vitro and when the cells were transplanted into immunodeficient mice. Conversely, knocking down expression of ILK in ARMS cells abrogated both JNK signaling and tumor cell growth. Further analysis revealed that the protein product of the fusion gene that characterizes ARMS downregulated JNK1 expression, providing mechanistic insight into the opposing roles of ILK in ARMS and ERMS. The authors therefore suggest it should be possible to identify patients with ARMS who would benefit from an anticancer therapeutic that targets ILK.

In an accompanying commentary, Charles Keller and colleagues concur with the authors that targeting ILK might provide a therapeutic strategy tailored to the treatment of ARMS. However, they caution that further studies are needed, in part because of the high rate of misdiagnosis of ARMS versus ERMS.


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Edifecs(TM) and Axway Announce a Partnership Targeting Innovative HIPAA 5010 Migration Solutions.
2. Stem Cell Study Offers Hope for Targeting Tumors
3. Migraine prevention by targeting glutamate receptors?
4. Targeting oxidized cysteine through diet could reduce inflammation and lower disease risk
5. Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls
6. Targeting the protein AEG1 impairs human liver cancer growth in mice
7. Tobacco Companies Targeting Teens, Study Says
8. APIC 2009 Targeting Zero Initiative Offers Practical Tools, Evidence-Based Elimination Strategies to Prevent the Deadliest Healthcare-Associated Infections
9. Targeting Cancers Own Stem Cells to Fight Recurrence
10. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
11. Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... Cary, NC (PRWEB) , ... January 15, 2017 ... ... to announce that Albertsons Companies has achieved accreditation for its specialty care services. ... accreditation and its own in-house specialty care service for pharmacy patients. , Accreditation ...
(Date:1/15/2017)... ... 14, 2017 , ... Wondering where to go this Valentine's Day? Well, there ... for a romantic, lobster feast in the comfort of your own home. Lobster Gram ... dinners will be featured until February 15th, 2017. , Romantic Dinner one is ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy living brand Moody ... activated charcoal products. With more and more people opting to go organic in ... how they cater to specific needs. , Moody Zook focused particularly on their ...
(Date:1/14/2017)... ... 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition which allows users ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , TransFreeze Volume ... from one clip to the next. , To use “Cut-Out First” presets, choose ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... A January ... top five procedures for 2017 according to the publication, with an emphasis on some ... Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., who is known more casually to his patients and ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... NEW YORK , Jan. 16, 2017 /PRNewswire/ ... global peripherally inserted central catheters market for the ... is to offer updates and information related to ... catheters market. This comprehensive market study demonstrates the ... current environment and future status of the global ...
(Date:1/16/2017)... , Jan. 16, 2017 The global pacemaker ... 2025, according to a new report by Grand View ... with the availability of medical coverage is a key ... addition, technological enhancements in these devices are supporting the ... Diseases (CVDs) is a high-impact growth rendering driver for ...
(Date:1/16/2017)... HOUSTON , Jan. 16, 2017 ... of Potts Law Firm, was recently appointed Liaison Counsel ... Proceedings (JCCP) for all Xarelto cases. In this role, ... plaintiff parties and will actively assist the Court and ... with Milstein Adelman Jackson Fairchild & ...
Breaking Medicine Technology: